Lawsuit alleges undisclosed stomach risks from Ozempic, Mounjaro.
In: Internal Medicine News, 2023-08-01, S. 86-86
Online
Zeitungsartikel
Zugriff:
The article informs a lawsuit filed by a woman with type 2 diabetes against the makers of the drugs Ozempic and Mounjaro. It discusses alleging inadequate warnings about severe stomach problems caused by these medications, including vomiting, diarrhea & gastroparesis; drugs' FDA approval for treating type 2 diabetes and their known weight loss properties; and lawsuit claims that the pharmaceutical companies failed to sufficiently disclose these gastrointestinal risks associated with the drugs.
Titel: |
Lawsuit alleges undisclosed stomach risks from Ozempic, Mounjaro.
|
---|---|
Autor/in / Beteiligte Person: | O'Mary, Lisa |
Link: | |
Zeitschrift: | Internal Medicine News, 2023-08-01, S. 86-86 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
ISSN: | 1097-8690 (print) |
Schlagwort: |
|
Sonstiges: |
|